StockTipsArenaBeta

BUY Natco Pharma Ltd — Dhupesh Dhameja, SAMCO Securities

BUYNatco Pharma Ltd
Natco Pharma share price target & all analyst calls

byDhupesh Dhameja, SAMCO SecuritiesHorizon: 1–3 months30 Mar 2026via CNBC Awaaz.

Entry₹1,000Stated
Target₹1,150
Total upside +15.00% (call closed)
Stop loss₹972-2.80% risk
Exit₹97230 Mar 2026, 3:25 pm
Stop-loss hit-2.80%
Follow Dhupesh Dhameja for new callsGet alertsWatch NATCOPHARM for new buy/sell callsGet alertsSee 1 active Short-term call on NATCOPHARMSee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:42 pm IST
1 supporting0 opposing
Supports the BUY call (1)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·27 Mar · 3d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Natco Pharma

All analyst calls on Natco Pharma

More from Dhupesh Dhameja, SAMCO Securities

Every call and its outcome